13F Holdings
中文EN

PRPO Precipio, Inc.

Laboratory Analytical Instruments · Nasdaq · SEC CIK 1043961 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY21.8%
TTM net income YoY8.8%
TTM EPS YoY27.2%
Revenue 3-yr CAGR27.9%
Net income 3-yr CAGR—

Margins

Gross margin44.6%
Operating margin-5.3%
Net margin-4.1%
FCF margin5.0%
EBITDA margin-1.1%

Returns

ROE-8.0%
ROA-5.3%
ROIC (approx.)-10.1%
Asset turnover1.30x

Leverage & solvency

Liabilities / assets31.5%
Debt / equity0.02x
Current ratio1.77x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-1.49x
Accruals ratio-13.3%
Payout ratio—
Capex / revenue1.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY2023*2023-12-31FY2022*2022-12-31FY2021*2021-12-31
Income statement
Revenue$24.05M$18.53M$15.20M$9.41M$8.85M
Cost of revenue$13.34M$10.97M$9.18M$6.90M$6.46M
Gross profit$10.71M$7.56M$6.02M$2.51M$2.39M
R&D expense$1.60M$1.30M$1.70M$1.70M$1.30M
Operating income-$1.20M-$4.22M-$7.62M-$12.80M-$9.61M
Pretax income-$363,000-$4.29M-$5.85M-$12.18M-$8.52M
Income tax$0$0$0$0$0
Net income-$363,000-$4.29M-$5.85M-$12.20M-$8.53M
EBITDA$43,000-$3.02M-$6.39M-$11.58M-$8.48M
EPS (basic)-0.23-2.93-4.51-10.73-0.40
EPS (diluted)-0.23-2.93-4.51-10.73-0.40
Weighted avg. shares (diluted)1.61M1.47M1.30M1.14M21.10M
Balance sheet
Cash & equivalents$2.65M$1.39M$1.50M$3.44M$11.67M
Receivables$1.98M$799,000$1.30M$1.04M$697,000
Inventory$935,000$724,000$384,000$708,000$564,000
Current assets$6.04M$3.45M$3.68M$5.71M$13.48M
PP&E, net$729,000$719,000$739,000$877,000$836,000
Intangibles$10.92M$11.87M$12.82M$13.77M$14.72M
Total assets$21.32M$17.00M$18.10M$21.50M$30.44M
Current liabilities$3.75M$4.27M$3.14M$4.36M$4.21M
Short-term debt$30,000$297,000$235,000$255,000$26,000
Long-term debt$47,000$77,000$106,000$134,000$160,000
Total debt$77,000$374,000$341,000$389,000$186,000
Total liabilities$6.76M$4.90M$3.67M$5.14M$5.83M
Shareholders' equity$14.56M$12.09M$14.43M$16.30M$24.56M
Net debt-$2.57M-$1.01M-$1.16M-$3.06M-$11.48M
Shares outstanding1.78M1.49M1.42M1.14M22.71M
Cash flow statement
Operating cash flow$685,000$439,000-$3.56M-$7.72M-$6.58M
Capital expenditure$326,000$223,000$126,000$277,000$682,000
Free cash flow$359,000$216,000-$3.69M-$8.00M-$7.26M
Investing cash flow-$326,000-$223,000-$126,000-$277,000-$682,000
Financing cash flow$903,000-$329,000$1.74M-$225,000$16.27M
Depreciation & amortization$1.25M$1.20M$1.23M$1.22M$1.13M
Stock-based compensation$1.21M$1.49M$1.56M$3.80M$1.88M

Free plan shows the latest 5 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.